semaglutide market Liraglutide and Size, Share and Forecast 2032 Semaglutide - Market Share Analysis,

Lee YH, Kim JH, Kim SR et al (2017) Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness

While these agents are not recommended during pregnancy, their use in the preconception, periconception, and postpartum periods is increasing

Be sure to work with your practitioner who knows your case to decide what is right for you

Note: Market size and forecast figures in this report are generated using Mordor Intelligences proprietary estimation framework, updated with the latest available data and insights as of 2026

In patients with chronic kidney disease but not cardiovascular disease, the NNT is 77 (95% CI, 56 to 167) over five years